# Ramez N. Eskander

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ramez-n-eskander/

## Facts

| Field | Value |
| --- | --- |
| Citations | 6,263 |
| Field | Ovarian cancer diagnosis and treatment |
| h-index | 39 |
| i10-index | 89 |
| Last Known Institution | UC San Diego Health System |
| OpenAlex ID | https://openalex.org/A5068446974 |
| ORCID iD | 0000-0002-2101-1935 |
| Works | 286 |

## Researcher papers

- [Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer](https://scholariq.org/papers/pembrolizumab-plus-chemotherapy-in-advanced-endometrial-cancer/)
- [Accuracy of Ultrasonography and Magnetic Resonance Imaging in the Diagnosis of Placenta Accreta](https://scholariq.org/papers/accuracy-of-ultrasonography-and-magnetic-resonance-imaging-in-the-diagnosis-of/)
- [Effect of Predelivery Diagnosis in 99 Consecutive Cases of Placenta Accreta](https://scholariq.org/papers/effect-of-predelivery-diagnosis-in-99-consecutive-cases-of-placenta-accreta/)
- [Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy](https://scholariq.org/papers/real-world-data-from-a-molecular-tumor-board-demonstrates-improved-outcomes-with/)
- [Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel](https://scholariq.org/papers/validation-of-microsatellite-instability-detection-using-a-comprehensive-plasma/)
- [Advances in Ovarian Cancer Care and Unmet Treatment Needs for Patients With Platinum Resistance](https://scholariq.org/papers/advances-in-ovarian-cancer-care-and-unmet-treatment-needs-for-patients-with/)
- [Early-stage multi-cancer detection using an extracellular vesicle protein-based blood test](https://scholariq.org/papers/early-stage-multi-cancer-detection-using-an-extracellular-vesicle-protein-based/)
- [Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG Oncology/Gynecologic Oncology Group study](https://scholariq.org/papers/early-initiation-of-chemotherapy-following-complete-resection-of-advanced/)
- [Incorporation of anti-angiogenesis therapy in the management of advanced ovarian carcinoma—Mechanistics, review of phase III randomized clinical trials, and regulatory implications](https://scholariq.org/papers/incorporation-of-anti-angiogenesis-therapy-in-the-management-of-advanced-ovarian/)
- [Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer](https://scholariq.org/papers/adding-immunotherapy-to-first-line-treatment-of-advanced-and-metastatic/)
- [Rucaparib maintenance for newly diagnosed advanced ovarian cancer: interim overall survival, progression-free survival, and safety at 5 years of follow-up from the phase III ATHENA-MONO/GOG-3020/ENGOT-ov45 study](https://scholariq.org/papers/rucaparib-maintenance-for-newly-diagnosed-advanced-ovarian-cancer-interim/)

## Researcher topics

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

## Researcher university

- [UC San Diego Health System](https://scholariq.org/institutions/uc-san-diego-health-system/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.